Neurogene Inc. Increase (Decrease) in Accounts and Other Receivables
Neurogene Inc. (NGNE) reported Increase (Decrease) in Accounts and Other Receivables of -$34.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2016-03-14
- Neurogene Inc. increase (decrease) in accounts and other receivables for the quarter ending 2015-12-31 was $12.00K.
- Neurogene Inc. increase (decrease) in accounts and other receivables for the quarter ending 2015-09-30 was -$53.00K, a 223.26% decline year-over-year.
- Neurogene Inc. increase (decrease) in accounts and other receivables for the quarter ending 2015-06-30 was $15.00K.
- Neurogene Inc. increase (decrease) in accounts and other receivables for the quarter ending 2015-03-31 was -$8.00K, a 120.51% decline year-over-year.
- Neurogene Inc. increase (decrease) in accounts and other receivables for fiscal 2015 was -$34.00K, a 191.89% decline from fiscal 2014.
- Neurogene Inc. increase (decrease) in accounts and other receivables for fiscal 2014 was $37.00K.
- Neurogene Inc. increase (decrease) in accounts and other receivables for fiscal 2013 was -$599.00.
- Neurogene Inc. increase (decrease) in accounts and other receivables for fiscal 2012 was -$190.65K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 6 month as first filed | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 9 month as first filed | Increase (Decrease) in Accounts and Other Receivables 12 month | Increase (Decrease) in Accounts and Other Receivables 12 month as first filed | Increase (Decrease) in Accounts and Other Receivables 123 month |
|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$41.00K derived: sum of 2 quarters · filed 2016-03-14 | -$26.00K derived: sum of 3 quarters · filed 2016-03-14 | -$34.00K 10-K · filed 2016-03-14 | |||||
| 2015-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$38.00K derived: sum of 2 quarters · filed 2015-11-10 | -$46.00K 10-Q · filed 2015-11-10 | -$57.00K derived: sum of 4 quarters · filed 2016-03-14 | |||||
| 2015-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $7.00K 10-Q · filed 2015-08-06 | -$4.00K derived: sum of 3 quarters · filed 2016-03-14 | $39.00K derived: sum of 4 quarters · filed 2016-03-14 | |||||
| 2015-03-31 | -$8.00K 10-Q · filed 2015-05-12 | -$19.00K derived: sum of 2 quarters · filed 2016-03-14 | $24.00K derived: sum of 3 quarters · filed 2016-03-14 | -$9.15K derived: sum of 4 quarters · filed 2016-03-14 | |||||
| 2014-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $32.00K derived: sum of 2 quarters · filed 2016-03-14 | -$1.15K derived: sum of 3 quarters · filed 2016-03-14 | $37.00K 10-K · filed 2016-03-14 | $37.50K 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $9.85K derived: sum of 2 quarters · filed 2015-11-10 | $48.00K 10-Q · filed 2015-11-10 | $48.30K 10-Q · filed 2014-11-04 | $42.70K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | -$33.15K 10-Q · filed 2014-08-11 | $5.00K 10-Q · filed 2015-08-06 | $5.43K 10-Q · filed 2014-08-11 | -$297.00 derived: sum of 3 quarters · filed 2015-05-12 | -$7.77K derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2014-03-31 | $39.00K 10-Q · filed 2015-05-12 | $38.58K 10-Q · filed 2014-05-13 | $32.85K derived: sum of 2 quarters · filed 2015-05-12 | $25.39K derived: sum of 3 quarters · filed 2015-05-12 | $38.23K derived: sum of 4 quarters · filed 2015-05-12 | $66.52K 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | -$6.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$13.62K derived: sum of 2 quarters · filed 2015-03-16 | -$769.00 derived: sum of 3 quarters · filed 2015-03-16 | -$599.00 10-K · filed 2015-03-16 | |||||
| 2013-09-30 | -$7.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $5.38K derived: sum of 2 quarters · filed 2014-11-04 | $5.55K 10-Q · filed 2014-11-04 | ||||||
| 2013-06-30 | $12.85K 10-Q · filed 2014-08-11 | $13.02K 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | $170.00 10-Q · filed 2014-05-13 | ||||||||
| 2012-12-31 | -$190.65K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |